Evidence map›Paper›PMID 12028457›Full record

ArticleKidney international2002

Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III.

Amit X Garg, Bryce A Kiberd, William F Clark, R Brian Haynes, Catherine M Clase

Registry-linked trialOpen access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Kidney international, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04215445 (Effect of Sodium Glucose co Transporter 2), which is not on this map. Cited by 103 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 3 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04215445 phase4unknown statusstarted 2019, after this paper: background citation

Effect of Sodium Glucose co Transporter 2 (SGLT2) Inhibition on Optical Coherence Tomography Angiography (OCT-A) Parameters in Diabetic Chronic Kidney Disease (CKD)

Ran2019Enrolled90Registered outcomes3Posted comparisons0ConditionsChronic Kidney Diseases, Diabetes Mellitus, Diabetic RetinopathyArmsempagliflozin 25 mg, OCT-A
Open the trial in the graph
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 3 syntheses or guidelines pooled it, 350 citations in OpenAlex.

  1. Chronic kidney disease.BMJ clinical evidence · 2015
    Pooled it
  2. Renal failure (chronic).BMJ clinical evidence · 2011
    Pooled it
  3. Pooled it
  4. Brain MRI Volume Findings in Diabetic Adults With Albuminuria: The ACCORD-MIND Study.The journals of gerontology. Series A, Biological sciences and medical sciences · 2016
    Trial
  5. Albuminuria and cognitive decline in people with diabetes and normal renal function.Clinical journal of the American Society of Nephrology : CJASN · 2013
    Trial
  6. Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures.Clinical journal of the American Society of Nephrology : CJASN · 2013
    Trial
  7. Trial
  8. Trial
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amit X GargDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada. amitg@mcmaster.ca
Bryce A Kiberd
William F Clark
R Brian Haynes
Catherine M Clase
McMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA number of screening criteria, applied either at a single point in time or serially, can be used for the purpose of identifying individuals at risk of end-stage renal disease (ESRD). This study focused on two such criteria measured on a single occasion, proteinuria and renal insufficiency, and examined their prevalence in a sample representative of the adult U.S. non-institutionalized population. Such knowledge guides the utility of population screening to prevent ESRD.

methodsThe prevalence of albuminuria (microalbuminuria and macroalbuminuria from a random urine albumin-to-creatinine ratio) and renal insufficiency [glomerular filtration rate (GFR) estimated from serum creatinine] was determined in different age categories in various adult screening groups in the cross-sectional Third National Health and Nutrition Examination Survey (NHANES III).

resultsA total of 14,622 adult participants were included in the analysis. In the general population, 8.3% and 1.0% of participants demonstrated microalbuminuria and macroalbuminuria, respectively. To identify one case of albuminuria, one would need to screen three persons with diabetes mellitus, seven non-diabetic hypertensive persons, or six persons over the age of 60. When albuminuria and renal insufficiency were considered together, it was clear that these tests were identifying different segments of the population; 37% of participants with a GFR less than 30 mL/min/1.73 m2 demonstrated no albuminuria. Non-albuminuric renal insufficiency was most evident in the ages of 60 to 79; 34% of diabetics, and 63% of non-diabetic hypertensives with a GFR less than 30 mL/min/1.73 m2 demonstrated no albuminuria.

conclusionsAlbuminuria is prevalent, and when considered together, screening tests of albuminuria and renal insufficiency measured on a single occasion identify different segments of the population. The prevalence of albuminuria and renal insufficiency in populations of interest should be considered, as this knowledge has implications for the effectiveness of screening.

Indexed as

Mass ScreeningAdultAgedAged, 80 and overAge DistributionAlbuminuriaCross-Sectional StudiesFemaleGlomerular Filtration RateHumansMaleMiddle AgedNutrition SurveysPrevalenceRenal Insufficiency

Identifiers

PMID12028457
OpenAlexW2087580623

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.